Prosight Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001617201

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q3 2024 · 43 positions · Total reported value $380.13M · Top-10 concentration 57.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.6% · 9 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 99.9% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.1% · vs SPY -3.2% · Prev Value $580.35M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -6.1% · vs SPY -8.3% · Latest Value $515.48M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, Prosight Management, LP disclosed 43 equity positions with a combined reported value of $380.13M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 57.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2024 were ADCT ($30.35M), LKFT ($29.62M), BBIO ($27.67M). By sector, the heaviest allocations are Health Care 85.7%, Financials 0.2%. Versus the prior quarter, allocation shifted toward Health Care (+3.0pp), Other (+0.9pp) and away from Consumer Staples (-0.7pp), Consumer Discretionary (-3.2pp).

Versus the prior quarter, Prosight Management, LP opened 9 new positions, trimmed 12 and fully exited 13, a turnover rate of 75.6% of positions. The portfolio's overlap with the prior quarter was 48% of names.

The largest new positions opened in Q3 2024 were MCK ($17.71M), JANX ($9.31M), HAE ($5.22M).

Of the 13 positions fully exited versus the prior quarter, the largest were KELYA ($10.54M), ALKS ($6.63M), KIDS ($5.76M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • MCK MCKESSON CORP · $17.71M
  • JANX JANUX THERAPEUTICS INC · $9.31M
  • HAE HAEMONETICS CORP MASS · $5.22M
  • LIVN LIVANOVA PLC · $4.73M
  • CVSI CASSAVA SCIENCES INC · $4.38M
  • BPMC BLUEPRINT MEDICINES CORP · $4.36M
  • CTMX CYTOMX THERAPEUTICS INC. · $3.57M
  • SGHT SIGHT SCIENCES INC · $3.35M

Fully Exited (vs previous quarter)

  • KELYA KELLY SVCS INC · prev qtr: $10.54M
  • ALKS ALKERMES PLC · prev qtr: $6.63M · history
  • KIDS ORTHOPEDIATRICS CORP · prev qtr: $5.76M
  • OPCH OPTION CARE HEALTH INC · prev qtr: $5.68M
  • RLAY RELAY THERAPEUTICS INC · prev qtr: $2.51M
  • BCRX BIOCRYST PHARMACEUTICALS INC · prev qtr: $2.46M
  • CVS CVS HEALTH CORP · prev qtr: $2.36M
  • MDT MEDTRONIC PLC · prev qtr: $2.36M

Insider Transactions (Form 4)

Latest Prosight Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Prosight Management, LP is an SEC-registered 13F filer based in Dallas, TX, United States. As of Q2 2026 it reported 36 US equity positions with a combined value of $580.35M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: DALLAS, TX, United States
  • SEC registration: 801-108047 (status: Approved), registered 2016-07-01
  • Regulatory AUM (Form ADV): $1.04B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: prosightcapital.com

Portfolio Structure

  • 36 positions · $580.35M reported value (Q2 2026)
  • Top 10 holdings = 70.7% of reported value
  • Largest position: LKFT (LAKEFRONT BIOTHERAPEUTICS NV) at 10.6%
  • Average position size: $16.12M

Sector Tilt

  • Health Care 83.6%
  • Information Technology 3.2%
  • (classified holdings cover 87% of value)

Quarterly Activity

  • Q2 2026: 5 new, 16 added, 15 reduced, 15 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 85.7%
Financials 0.2%
Other 14.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 9.64M $30.35M 7.99%
7.99%
Add
2 1.03M $29.62M 7.79%
7.79%
Reduce
3 1.09M $27.67M 7.28%
7.28%
Add
4 9.08M $23.61M 6.21%
6.21%
Add
5 4.90M $20.44M 5.38%
5.38%
Add
6 1.72M $19.87M 5.23%
5.23%
Reduce
7 465.82K $18.17M 4.78%
4.78%
Add
8 165.60K $17.88M 4.70%
4.70%
Reduce
9 35.82K $17.71M 4.66%
4.66%
New
10 705.11K $13.78M 3.62%
3.62%
Add
11 700.00K $12.98M 3.42%
3.42%
Add
12 917.60K $11.52M 3.03%
3.03%
Reduce
13 2.80M $10.79M 2.84%
2.84%
Add
14 160.00K $10.73M 2.82%
2.82%
Add
15 554.10K $10.67M 2.81%
2.81%
Hold
16 370.00K $10.55M 2.77%
2.77%
Add
17 192.70K $10.17M 2.68%
2.68%
Reduce
18 205.00K $9.31M 2.45%
2.45%
New
19 483.47K $8.09M 2.13%
2.13%
Add
20 62.00K $7.14M 1.88%
1.88%
Add
21 1.98M $5.42M 1.43%
1.43%
Reduce
22 65.00K $5.22M 1.37%
1.37%
New
23 90.00K $4.73M 1.24%
1.24%
New
24 410.83K $4.44M 1.17%
1.17%
Reduce
25 148.90K $4.38M 1.15%
1.15%
New
26 47.10K $4.36M 1.15%
1.15%
New
27 137.61K $4.17M 1.10%
1.10%
Add
28 3.02M $3.57M 0.94%
0.94%
New
29 531.22K $3.35M 0.88%
0.88%
New
30 48.00K $3.04M 0.80%
0.80%
Reduce
31 159.37K $2.94M 0.77%
0.77%
New
32 130.00K $2.68M 0.71%
0.71%
New
33 570.62K $1.79M 0.47%
0.47%
Add
34 208.20K $1.73M 0.46%
0.46%
New
35 2.21M $1.58M 0.42%
0.42%
Reduce
36 372.16K $1.32M 0.35%
0.35%
Add
37 2.80K $915.29K 0.24%
0.24%
New
38 26.07K $908.89K 0.24%
0.24%
New
39 729.21K $860.47K 0.23%
0.23%
Reduce
40 39.13K $572.15K 0.15%
0.15%
Reduce
41 190.00K $473.10K 0.12%
0.12%
Reduce
42 5.67K $359.28K 0.10%
0.10%
New
43 86.80K $302.93K 0.08%
0.08%
Reduce

FAQ

What did Prosight Management, LP buy in 2024-Q3?

In its 2024-Q3 13F filing, Prosight Management, LP reported 43 equity positions worth $380.13M in aggregate; its largest disclosed positions were ADCT ($30.35M), LKFT ($29.62M), BBIO ($27.67M).

How large is Prosight Management, LP's portfolio?

Prosight Management, LP reported $380.13M of long equity holdings across 43 positions as of 2024-Q3. Top-10 holdings account for 57.6% of reported value.

What is Prosight Management, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/prosight-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →